Disc Medicine, Inc. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2026-06-30: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
- 2026-03-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
- 2025-12-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
- 2025-09-30: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock, Liquidation Preference, Value | Preferred Stock, Dividend Rate, Percentage | Preferred Stock Convertible Conversion Ratio |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | 10.00M shares 10-Q · filed 2026-07-30 | 0.00 shares 10-Q · filed 2026-07-30 | 0.00 shares 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 10-Q · filed 2026-05-05 | 10.00M shares 10-Q · filed 2026-05-05 | 0.00 shares 10-Q · filed 2026-05-05 | 0.00 shares 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $0.00 10-Q · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | 10.00M shares 10-Q · filed 2026-07-30 | 0.00 shares 10-Q · filed 2026-07-30 | 0.00 shares 10-Q · filed 2026-07-30 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | 10.00M shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | 10.00M shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 10-Q · filed 2025-05-07 | 10.00M shares 10-Q · filed 2025-05-07 | 0.00 shares 10-Q · filed 2025-05-07 | 0.00 shares 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | 10.00M shares 10-K · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | 10.00M shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | 10.00M shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | 10.00M shares 10-Q · filed 2024-05-09 | 0.00 shares 10-Q · filed 2024-05-09 | 0.00 shares 10-Q · filed 2024-05-09 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | 10.00M shares 10-K · filed 2025-02-27 | 0.00 shares 10-K · filed 2025-02-27 | 0.00 shares 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | 10.00M shares 10-Q · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | 0.00 shares 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | 10.00M shares 10-Q · filed 2023-08-11 | 0.00 shares 10-Q · filed 2023-08-11 | 0.00 shares 10-Q · filed 2023-08-11 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | 10.00M shares 10-Q · filed 2023-05-15 | 0.00 shares 10-Q · filed 2023-05-15 | 0.00 shares 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 | 10.00M shares 10-K · filed 2024-03-21 | 0.00 shares 10-K · filed 2024-03-21 | 0.00 shares 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | 10.00M shares 10-Q · filed 2022-11-10 | 0.00 shares 10-Q · filed 2022-11-10 | 0.00 shares 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | 10.00M shares 10-Q · filed 2022-08-11 | 0.00 shares 10-Q · filed 2022-08-11 | 0.00 shares 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-06 | $0.00 10-Q · filed 2022-05-06 | 10.00M shares 10-Q · filed 2022-05-06 | 0.00 shares 10-Q · filed 2022-05-06 | 0.00 shares 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | $141.86M 10-K · filed 2023-03-31 | $0.00 10-Q · filed 2022-11-10 | 84.17M shares 10-K · filed 2023-03-31 | 84.17M shares 10-K · filed 2023-03-31 | 84.17M shares 10-K · filed 2023-03-31 | $145.00M 10-K · filed 2023-03-31 | 8.00% 10-K · filed 2023-03-31 | 100.00% 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | 10.00M shares 10-Q · filed 2021-11-15 | 0.00 shares 10-Q · filed 2021-11-15 | 0.00 shares 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | 10.00M shares 10-Q · filed 2021-08-12 | 0.00 shares 10-Q · filed 2021-08-12 | 0.00 shares 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | 10.00M shares 10-Q · filed 2021-05-13 | 0.00 shares 10-Q · filed 2021-05-13 | 0.00 shares 10-Q · filed 2021-05-13 | ||||
| 2021-02-05 | $0.00 10-Q · filed 2022-11-10 | 10.00M shares 10-Q · filed 2022-11-10 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 | 10.00M shares 10-K · filed 2022-03-10 | 0.00 shares 10-K · filed 2022-03-10 | 0.00 shares 10-K · filed 2022-03-10 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | 1.00M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |